ATE305934T1 - Verfahren zur herstellung von maytansinol - Google Patents

Verfahren zur herstellung von maytansinol

Info

Publication number
ATE305934T1
ATE305934T1 AT02726608T AT02726608T ATE305934T1 AT E305934 T1 ATE305934 T1 AT E305934T1 AT 02726608 T AT02726608 T AT 02726608T AT 02726608 T AT02726608 T AT 02726608T AT E305934 T1 ATE305934 T1 AT E305934T1
Authority
AT
Austria
Prior art keywords
maytansinol
producing
preparing
producing maytansinol
unreduced
Prior art date
Application number
AT02726608T
Other languages
English (en)
Inventor
Gerald J Terfloth
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE305934T1 publication Critical patent/ATE305934T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT02726608T 2001-03-16 2002-03-12 Verfahren zur herstellung von maytansinol ATE305934T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27679201P 2001-03-16 2001-03-16
PCT/US2002/007424 WO2002074775A1 (en) 2001-03-16 2002-03-12 Process for preparing maytansinol

Publications (1)

Publication Number Publication Date
ATE305934T1 true ATE305934T1 (de) 2005-10-15

Family

ID=23058083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02726608T ATE305934T1 (de) 2001-03-16 2002-03-12 Verfahren zur herstellung von maytansinol

Country Status (7)

Country Link
US (2) US20020156274A1 (de)
EP (1) EP1373273B1 (de)
JP (1) JP2004526734A (de)
AT (1) ATE305934T1 (de)
DE (1) DE60206477T2 (de)
ES (1) ES2248550T3 (de)
WO (1) WO2002074775A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333410B1 (en) 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
ATE446317T1 (de) 2001-05-11 2009-11-15 Ludwig Inst For Cancer Res Ltd Spezifische bindungsproteine und ihre verwendung
JP2005525423A (ja) * 2002-05-13 2005-08-25 スミスクライン・ビーチャム・コーポレイション メイタンシノールの調製方法
US20050261493A1 (en) * 2002-08-08 2005-11-24 Mark Fulston Methods for the isolation and purification of ansamitocins
US7432088B2 (en) * 2003-05-08 2008-10-07 Immunogen Inc. Methods for the production of ansamitocins
US20090208556A1 (en) * 2004-10-29 2009-08-20 Regents Of The University Of California, The Porous photonic crystals for drug delivery to the eye
US20070135629A1 (en) * 2005-12-08 2007-06-14 Millennium Pharmaceuticals, Inc. Isolation of ansamitocins
JP5276017B2 (ja) 2007-01-25 2013-08-28 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド Egfr変異体仲介性疾患の治療における抗egfr抗体の使用
CN101688229B (zh) 2007-03-15 2013-06-12 路德维格癌症研究所 包含egfr抗体和src抑制剂的组合物及其在制备用于治疗哺乳动物癌症的药物中的用途
CN101896503B (zh) 2007-08-14 2018-05-22 路德维格癌症研究所有限公司 靶向egf受体的单克隆抗体175及其衍生物和用途
CN102933231B (zh) 2010-02-10 2015-07-29 伊缪诺金公司 Cd20抗体及其用途
CN103604803B (zh) * 2013-11-11 2015-11-25 深圳大学 一种快速检测红酒中铁离子含量的方法
JP6894423B2 (ja) 2015-07-09 2021-06-30 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California 融合性リポソーム被覆多孔質ケイ素ナノ粒子
ES2949511T3 (es) * 2019-03-01 2023-09-29 Celgene Corp Preparación de maitansinol
JPWO2021107133A1 (de) 2019-11-29 2021-06-03

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4162940A (en) * 1977-03-31 1979-07-31 Takeda Chemical Industries, Ltd. Method for producing Antibiotic C-15003 by culturing nocardia
US4151042A (en) * 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
CA2006408A1 (en) * 1988-12-27 1990-06-27 Susumu Iwasa Bispecific monoclonal antibody, its production and use
US5208020A (en) * 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US6333410B1 (en) * 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
US6441163B1 (en) * 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents

Also Published As

Publication number Publication date
EP1373273A4 (de) 2004-07-14
EP1373273B1 (de) 2005-10-05
EP1373273A1 (de) 2004-01-02
ES2248550T3 (es) 2006-03-16
US20020156274A1 (en) 2002-10-24
US20050113571A1 (en) 2005-05-26
DE60206477D1 (de) 2006-02-16
WO2002074775A1 (en) 2002-09-26
DE60206477T2 (de) 2006-06-22
JP2004526734A (ja) 2004-09-02

Similar Documents

Publication Publication Date Title
DE60206477D1 (de) Verfahren zur herstellung von maytansinol
DE4495679T1 (de) Verfahren und Vorrichtung zur Programmerweiterung zellularer mobiler Telefone
DE69223065D1 (de) Oberflächenmodifiziertes, poröses expandiertes polytetrafluoroäthylen und verfahren zur herstellung desselben
ATE129265T1 (de) Hartschaumstoff sowie verfahren zur herstellung desselben.
DE69103230D1 (de) 1-Pyridylimidazolderivat und Verfahren zur Herstellung und Anwendung.
ATE169180T1 (de) Verfahren zur herstellung überzogener mikrobieller pestizide und so hergestellte pestizide
AT4947U3 (de) Vollnarbiges rindnappaleder und verfahren zur herstellung desselben
DE69941954D1 (de) Oxetanderivate, oxetancopolymer, und verfahren zur herstellung von oxetanderivaten
DE60002286D1 (de) Verfahren zur Herstellung von Ketonen, Alkoholen und Hydroperoxiden
DE69616446T2 (de) Verfahren zur herstellung von alpha-haloketonen, alpha-halohydrinen und epoxiden
DE69708711T2 (de) Verfahren zur Herstellung von Stickstofftrifluorid
DE60121150D1 (de) Verfahren zur herstellung von ansamitocin
DE69109427D1 (de) Blockcopolymerdispersionen und Verfahren zur Herstellung von Blockcopolymerdispersionen.
ATE344273T1 (de) Verfahren zur herstellung von 21-hydroxy-6,19- oxidoprogesteron (21oh-6op)
DE69325452D1 (de) Verfahren zur herstellung von (s)-3-amino-1-substituiert-pirrolidine
DE59106383D1 (de) Verfahren und einrichtung zur oxidation von wasserstoff.
ATE229077T1 (de) Verfahren zur herstellung von lipstatin und tetrahydrolipstatin
DE59702009D1 (de) Verfahren zur herstellung von 1,4,7,10-tetraazacyclododecan und dessen derivaten
ATE210631T1 (de) Verfahren zur herstellung von iohexol
WO2003096782A3 (en) Process for preparing maytansinol
DE59106553D1 (de) Verfahren zur herstellung von chlorfluornitrobenzolen und difluornitrobenzolen.
DE69313297D1 (de) Benzofuranone, benzodifurantrione und verfahren zur herstellung von benzodifurandionen
ATE417131T1 (de) Verfahren zur herstellung von metallschaumkörpern auf basis von zink
ATE276988T1 (de) Verfahren zur herstellung von mannit
DE69707825D1 (de) Verfahren zur Herstellung von alicyclischen Hydrazin-derivaten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties